Organigram Holdings Inc. Announces At-The-Market place Equity Plan

MONCTON, New Brunswick, December 04, 2019–(Organization WIRE)–Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announced nowadays that it has established an at-the-marketplace equity system (the “ATM Program”) that enables the Corporation to situation up to C$55,000,000 (or its U.S. dollar equivalent) of prevalent shares (“Common Shares”) from treasury to the public from time to time, at the Corporation’s discretion. Any Widespread Shares sold in the ATM Plan will be sold via the Toronto Stock Exchange (the “TSX”), the NASDAQ International Choose Market place (the “NASDAQ”) or any other marketplace on which the Widespread Shares are listed, quoted or otherwise traded, at the prevailing marketplace value at the time of sale.

The volume and timing of distributions beneath the ATM Plan, if any, will be determined in the Corporation’s sole discretion. The ATM Plan will be productive till the earlier of December 25, 2021 and the issuance and sale of all of the Widespread Shares issuable pursuant to the ATM Plan, unless terminated prior to such date by the Corporation or the agents referred to under. Organigram intends to use the net proceeds from the ATM Plan, if any, to fund capital projects, for common corporate purposes and to repay indebtedness. As Widespread Shares distributed in the ATM Plan will be issued and sold at the prevailing marketplace value at the time of the sale, costs might differ amongst purchasers in the course of the period of the distribution.

Distributions of the Widespread Shares via the ATM Plan will be produced pursuant to the terms of an equity distribution agreement dated December four, 2019 amongst the Corporation, BMO Nesbitt Burns Inc., as Canadian agent, and BMO Capital Markets Corp., as U.S. agent (collectively, the “agents”).

The providing beneath the ATM Plan will be produced pursuant to a prospectus supplement dated December four, 2019 (the “Prospectus Supplement”) to the Corporation’s Canadian base shelf prospectus (the “Shelf Prospectus”) dated November 22, 2019, and pursuant to a prospectus supplement dated December four, 2019 (the “U.S. Prospectus Supplement”) to the Corporation’s U.S. base prospectus (the “U.S. Base Prospectus”) dated November 22, 2019 and integrated in its registration statement on Kind F-10, as amended (the “Registration Statement”) (File No. 333-234564). The Registration Statement was declared productive by the United States Securities and Exchange Commission (the “SEC”) on November 27, 2019. The Prospectus Supplement and the Shelf Prospectus are obtainable on the SEDAR web page maintained by the Canadian Securities Administrators at www.sedar.com, and the U.S. Prospectus Supplement, the U.S. Base Prospectus and the Registration Statement are obtainable on EDGAR at the SEC’s web page at www.sec.gov. Alternatively, the agents will send copies of the Prospectus Supplement and the Shelf Prospectus, or the U.S. Prospectus Supplement and the U.S. Base Prospectus, as applicable, upon request by contacting in Canada:

BMO Capital Markets, Brampton Distribution Centre C/O The Information Group of Providers, 9195 Torbram Road, Brampton, Ontario, L6S 6H2, or by phone at (905) 791-3151 Ext 4312, or by e mail at [email protected]

or in the U.S.:

BMO Capital Markets Corp., Consideration: Equity Syndicate Division, three Instances Square, New York, NY 10036, or by phone at (800) 414-3627, or by e mail at [email protected]

This news release does not constitute an provide to sell or the solicitation of an provide to invest in the Widespread Shares, nor shall there be any sale of these securities in any state or jurisdiction in which such an provide, solicitation or sale would be unlawful prior to registration or qualification beneath the securities laws of any such state or jurisdiction.

About Organigram Holdings Inc.:

Organigram Holdings Inc. is a NASDAQ and TSX listed organization whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived items in Canada.

Organigram is focused on creating higher-high quality, indoor-grown cannabis for individuals and adult recreational shoppers in Canada, as nicely as building international organization partnerships to extend the Corporation ‘s international footprint. Organigram has also created a portfolio of legal adult use recreational cannabis brands such as The Edison Cannabis Corporation, Ankr Organics and Trailblazer. Organigram’s major facility is positioned in Moncton, New Brunswick and the Corporation is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Original press release

Published by NCV Newswire

NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate higher high quality content material and facts about major cannabis corporations to support our readers filter out the noise and to remain on major of the most significant cannabis organization news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter